File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Low-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab

TitleLow-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab
Authors
Kwong, YLLoong, FKhong, PL
Keywordsadult
cancer recurrence
cancer regression
case report
classical Hodgkin lymphoma
Issue Date2019
PublisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00277/index.htm
Citation
Annals of Hematology, 2019, v. 98 n. 10, p. 2451-2455 How to Cite?
DOI: http://dx.doi.org/10.1007/s00277-019-03762-3
Persistent Identifierhttp://hdl.handle.net/10722/284050
ISSN
0939-5555
2021 Impact Factor: 4.030
2020 SCImago Journal Rankings: 1.079
ISI Accession Number ID
WOS:000484937900029

 

DC FieldValueLanguage
dc.contributor.authorKwong, YL-
dc.contributor.authorLoong, F-
dc.contributor.authorKhong, PL-
dc.date.accessioned2020-07-20T05:55:42Z-
dc.date.available2020-07-20T05:55:42Z-
dc.date.issued2019-
dc.identifier.citationAnnals of Hematology, 2019, v. 98 n. 10, p. 2451-2455-
dc.identifier.issn0939-5555-
dc.identifier.urihttp://hdl.handle.net/10722/284050-
dc.languageeng-
dc.publisherSpringer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00277/index.htm-
dc.relation.ispartofAnnals of Hematology-
dc.rightsThis is a post-peer-review, pre-copyedit version of an article published in [insert journal title]. The final authenticated version is available online at: http://dx.doi.org/[insert DOI]-
dc.subjectadult-
dc.subjectcancer recurrence-
dc.subjectcancer regression-
dc.subjectcase report-
dc.subjectclassical Hodgkin lymphoma-
dc.titleLow-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab-
dc.typeArticle-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.emailKhong, PL: plkhong@hku.hk-
dc.identifier.authorityKwong, YL=rp00358-
dc.identifier.authorityKhong, PL=rp00467-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s00277-019-03762-3-
dc.identifier.pmid31332470-
dc.identifier.scopuseid_2-s2.0-85069506621-
dc.identifier.hkuros311330-
dc.identifier.volume98-
dc.identifier.issue10-
dc.identifier.spage2451-
dc.identifier.epage2455-
dc.identifier.isiWOS:000484937900029-
dc.publisher.placeGermany-
dc.identifier.issnl0939-5555-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats